Chen and colleagues reported that some anti-inflammatory phytochemicals like EGCG appear to modulate the tumor microenvironment by repressing NF-kappaB (NF-κB, a proinflammatory transcription factor), and inhibiting pro-inflammatory cytokines like IL-6 and TNF-α in epithelial ovarian cancer [45]. Here, IL6 is linked to neoplasm.